Zepp Health (FRA:ST0) EPS without NRI: €-3.04 (TTM As of Mar. 2026)


FRA:ST0 Zepp Health Corp FRA:ST0
39 GF Score
Price €4.24
GF Value €3.17
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Zepp Health EPS without NRI?

Zepp Health FRA:ST0 +3.41% 39 EPS without NRI is €-3.04 as of Mar. 2026. GuruFocus rates FRA:ST0 with a GF Score™ of 39/100 and a GF Value™ of €3.17 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,902 Hardware companies, Zepp Health ranks better than 55.52% on this metric.

Zepp Health's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €-0.97. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €-3.04.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Zepp Health's EPS without NRI or its related term are showing as below:

FRA:ST0' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -21.9   Med: 10.85   Max: 189.1
Current: 5.1

During the past 11 years, Zepp Health's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 189.10% per year. The lowest was -21.90% per year. And the median was 10.85% per year.

FRA:ST0's 3-Year EPS without NRI Growth Rate is ranked better than
55.52% of 1902 companies
in the Hardware industry
Industry Median: 1.15 vs FRA:ST0: 5.10

Zepp Health's EPS (Diluted) for the three months ended in Mar. 2026 was €-1.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-3.43.

Zepp Health's EPS (Basic) for the three months ended in Mar. 2026 was €-1.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €-2.21.


Zepp Health  (FRA:ST0) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zepp Health EPS without NRI Related Terms


Zepp Health EPS without NRI Historical Data

* Premium members only.

The historical data trend for Zepp Health's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zepp Health EPS without NRI Chart

Zepp Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.87 -2.12 -1.30 -3.36 -1.64

Zepp Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.04 -0.28 -1.38 -0.41 -0.97

FRA:ST0 vs UEIC, AXIL, KOSS: EPS without NRI Comparison

For the Consumer Electronics subindustry, Zepp Health's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zepp Health PE Ratio without NRI vs Hardware Industry

For the Hardware industry and Technology sector, Zepp Health's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Zepp Health's PE Ratio without NRI falls into.


FRA:ST0
39GF Score
Zepp Health Corp FRA:ST0
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zepp Health EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-3.04 mean?
Zepp Health (FRA:ST0) has a EPS without NRI of €-3.04 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Zepp Health and its competitors. According to the industry distribution chart, Zepp Health ranks #846 out of 1902 companies in the Hardware industry, placing it in the top 44.5%.
Is Zepp Health's EPS without NRI too high?
Zepp Health's current EPS without NRI is €-3.04. Based on the distribution chart, Zepp Health ranks #846 out of 1902 companies in the Hardware industry, which is above the industry midpoint. Overall, Zepp Health has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zepp Health's EPS without NRI compare to UEIC and AXIL?
According to the Hardware industry distribution chart, Zepp Health ranks #846 out of 1902 companies for EPS without NRI. This puts Zepp Health in the upper half of its industry. The industry median EPS without NRI is 1.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Hardware company?
The median EPS without NRI among Hardware companies is 1.15, based on 1,902 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Zepp Health and its competitors. For the Hardware industry, the median EPS without NRI is 1.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zepp Health's current EPS without NRI is €-3.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zepp Health stock overvalued right now?
Based on GuruFocus' analysis, Zepp Health (FRA:ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.17, compared to a current price of €4.24 — trading 33.8% above its estimated fair value. The current EPS without NRI is €-3.04. Zepp Health's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Zepp Health (FRA:ST0), the current EPS without NRI is €-3.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zepp Health (FRA:ST0) Overvalued in 2026?

Based on GuruFocus' analysis, Zepp Health stock appears to be overvalued. The current stock price of €4.24 is trading 33.8% above its estimated GF Value™ of €3.17. GuruFocus considers Zepp Health to be Significantly Overvalued.

Key valuation signals for FRA:ST0:

  • EPS without NRI: €-3.04
  • GF Value™: €3.17 vs. price of €4.24 (33.8% above fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the FRA:ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zepp Health Business Description

Other Exchanges ZEPP:USA
Address Edisonweg 44 - B08, Gorinchem, ZH, NLD, 4207 HG
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands. Geographically, the group generates revenue from Asia-Pacific, Europe, North America and others.
39GF Score

Get the complete analysis for FRA:ST0

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.24
Price
€3.17
GF Value